Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2011-2-3
pubmed:abstractText
Naive B lymphocytes are generally thought to be poor APCs, and there is limited knowledge of their role in activation of CD8(+) T cells. In this article, we demonstrate that class I MHC Ag presentation by human naive B cells is enhanced by TLR9 agonists. Purified naive B cells were cultured with or without a TLR9 agonist (CpG oligodeoxynucleotide [ODN] 2006) for 2 d and then assessed for phenotype, endocytic activity, and their ability to induce CD8(+) T cell responses to soluble Ags. CpG ODN enhanced expression of class I MHC and the costimulatory molecule CD86 and increased endocytic activity as determined by uptake of dextran beads. Pretreatment of naive B cells with CpG ODN also enabled presentation of tetanus toxoid to CD8(+) T cells, resulting in CD8(+) T cell cytokine production and granzyme B secretion and proliferation. Likewise, CpG-activated naive B cells showed enhanced ability to cross-present CMV Ag to autologous CD8(+) T cells, resulting in proliferation of CMV-specific CD8(+) T cells. Although resting naive B cells are poor APCs, they can be activated by TLR9 agonists to serve as potent APCs for class I MHC-restricted T cell responses. This novel activity of naive B cells could be exploited for vaccine design.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1550-6606
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
186
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2080-6
pubmed:dateRevised
2011-10-6
pubmed:meshHeading
pubmed-meshheading:21239717-Adjuvants, Immunologic, pubmed-meshheading:21239717-Adult, pubmed-meshheading:21239717-Antigen-Presenting Cells, pubmed-meshheading:21239717-Antigens, CD86, pubmed-meshheading:21239717-B-Lymphocyte Subsets, pubmed-meshheading:21239717-CD8-Positive T-Lymphocytes, pubmed-meshheading:21239717-Cells, Cultured, pubmed-meshheading:21239717-Coculture Techniques, pubmed-meshheading:21239717-Cross-Priming, pubmed-meshheading:21239717-Endocytosis, pubmed-meshheading:21239717-G0 Phase, pubmed-meshheading:21239717-Gene Expression Regulation, pubmed-meshheading:21239717-Histocompatibility Antigens Class I, pubmed-meshheading:21239717-Humans, pubmed-meshheading:21239717-Ligands, pubmed-meshheading:21239717-Lymphocyte Activation, pubmed-meshheading:21239717-Oligodeoxyribonucleotides, pubmed-meshheading:21239717-Solubility, pubmed-meshheading:21239717-T-Lymphocytes, pubmed-meshheading:21239717-Toll-Like Receptor 9
pubmed:year
2011
pubmed:articleTitle
Presentation of soluble antigens to CD8+ T cells by CpG oligodeoxynucleotide-primed human naive B cells.
pubmed:affiliation
Division of Infectious Diseases and HIV Medicine, Case Western Reserve University, University Hospitals/Case Medical Center, Cleveland, OH 44106, USA. wei.jiang@case.edu
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural